Home Latin News Pfizer needs emergency distribution of its vaccine concurrently in US, Europe and Latin America — Autopresse.eu

Pfizer needs emergency distribution of its vaccine concurrently in US, Europe and Latin America — Autopresse.eu

Pfizer needs emergency distribution of its vaccine concurrently in US, Europe and Latin America — Autopresse.eu

Pfizer needs emergency distribution of its vaccine concurrently in US, Europe and Latin America — Autopresse.eu

2020-11-21 09:48:00

Pfizer needs emergency distribution of its vaccine concurrently in US, Europe and Latin America

Saturday, November twenty first 2020 – 09:48 UTC


Alejandro Cané, the North America chief of scientific and medical affairs for Pfizer, mentioned that Latin America and elsewhere on the planet ought to have a “related timeline” to the US

US drugmaker Pfizer Inc is hoping to quickly roll out its experimental COVID-19 vaccine round Latin America quickly after it will get emergency authorization in america, a senior govt mentioned, which could possibly be as early as subsequent month.

Alejandro Cané, the North America chief of scientific and medical affairs for Pfizer’s vaccines division, mentioned in Buenos Aires that Latin America and elsewhere on the planet ought to have a “related timeline” to america.

“At the start the thought is to have the vaccine licensed in america,” Cané mentioned. “We’re assured that within the subsequent weeks or month we could have the vaccine not solely in use within the U.S. and Europe, but additionally in Latin American international locations.”

Pfizer is making use of to U.S. well being regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the primary such utility, which marks a serious step towards offering safety in opposition to the lethal virus.

“The concept is simply to gather all the information from that trial and we’re ready now for suggestions from the FDA to have a VRBPAC (Vaccines and Associated Organic Merchandise Advisory Committee) assembly and after {that a} potential authorization for our emergency use authorization,” he mentioned.

“In that means, the vaccine could possibly be used and distributed in america,” he added, saying that authorization might come round 1-2 weeks after the VRBPAC assembly.

Cané mentioned that Pfizer had provide agreements in Chile, Mexico and Peru and that there have been a number of different conversations ongoing, together with in Argentina, the place the federal government has mentioned it might obtain 750,000 doses of the vaccine by December.

Pfizer and German companion BioNTech SE have reported ultimate trial outcomes exhibiting the vaccine was 95% efficient in stopping COVID-19, with no main security considerations.

Cané mentioned Pfizer was prepared to produce and distribute round 50 million doses of the vaccine, which requires ultra-low temperature storage, earlier than the tip of 2020, which might be cut up between america and the remainder of the world.

Nations round Latin America even have offers in place for vaccine doses from British drugmaker AstraZeneca Plc, China’s Sinovac Biotech and Russia’s Sputnik V vaccine.

Leave a Reply

Your email address will not be published.